Accessibility Menu
Univec logo

Univec(OTC) UNVC

Market Cap$8.07MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1997)-100%
5 Year-97%
1 Year+11%
1 Month+10%
$0.00
+0%
+0.00Today
Univec last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-29
Univec stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+33.33%USD 0.002026-07-22
1 month+10.34%USD 0.002026-06-29
3 month+53.33%USD 0.002026-04-30
Year to date+28%USD 0.002025-12-31
1 year+10.73%USD 0.002025-07-28
3 year-75%USD 0.012023-07-28
5 year-96.95%USD 0.112021-07-30
Since inception-99.96%USD 9.061997-04-24

Univec Financials at a Glance

Market Cap

$8.07MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$88.01K

Net Income (TTM)

-$1.21M

EPS (TTM)

-$0.00

P/E Ratio

-6.40

Dividend

$0.00

Beta (Volatility)

0.34 (Low)

Price

$0.00

Volume

1,003,430

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

N/A

UNVC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Univec

Univec, Inc. is a medical device firm specializing in the development, licensing, and sale of innovative products, primarily safety syringes. The company operates across the United States and internationally, focusing on enhancing patient safety and healthcare efficiency.

Products and Services
  • Auto-disable syringes for precise medication dispensing
  • Sliding sheath syringes to prevent needlestick injuries
  • Bifurcated needle safety syringes for smallpox vaccinations
Growth Outlook
  • Increasing global demand for safety syringes due to healthcare regulations
  • Expansion into international markets, particularly in developing countries
  • Potential partnerships with pharmaceutical companies for drug sample tracking
Financial Highlights
  • Recent quarterly revenue of $19,250, showing a growth trend
  • Trailing twelve months (TTM) revenue of $75,000, indicating market interest
  • Operating expenses have been managed, with a focus on reducing losses
Univec, Inc. is positioned in the healthcare sector, specifically within the drug manufacturers' industry, focusing on specialty and generic products. The company has developed a range of safety syringes that address critical healthcare needs, particularly in preventing needlestick injuries and ensuring accurate medication delivery. The growth outlook for Univec is promising, driven by increasing global demand for safety devices and potential expansion into new markets. The company is also exploring partnerships that could enhance its product offerings and market reach. Financially, Univec has shown a recent quarterly revenue increase, reflecting a positive trend in sales. The trailing twelve months revenue indicates a growing interest in its products, despite the challenges faced in managing operating expenses. The focus on reducing losses suggests a strategic approach to improving financial health. Overall, Univec, Inc. presents an intriguing opportunity for investors interested in the healthcare sector, particularly in innovative medical devices that enhance patient safety.
AI Generated • Jul 20, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

David L. Dalton, PhD

Website

www.univechealth.com

Headquarters

Owings Mills, MD 21202, US

UNVC Financials

Key Financial Metrics (TTM)

Gross Margin

13.66%

Operating Margin

-1441.94%

Net Income Margin

-1377.32%

Return on Equity

6.94%

Return on Capital

N/A

Return on Assets

-3776.67%

Earnings Yield

-15.63%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$8.07MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.52B

Volume

1.00M

Avg. Volume

1.31M

Financials (TTM)

Gross Profit

$12.03K

Operating Income

-$1.27M

EBITDA

-$1.26M

Operating Cash Flow

-$15.55M

Capital Expenditure

$1.00

Free Cash Flow

-$15.55M

Cash & ST Invst.

$0.00

Total Debt

$1.46M

Univec Performance Analysis

Univec annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 33,165-38.2%
20232023-12-31USD 21,044-36.5%
20242024-12-31USD 22,6487.6%
20252025-12-31USD 85,014275.4%
Univec sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3010.0%
Q32025-09-3086.8%
Q42025-12-31-47.6%
Q12026-03-3110.0%
Univec annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.0057.1%
20232023-12-31USD -0.00-9.1%
20242024-12-31USD -0.00-70.0%
20252025-12-31USD -0.0066.7%
Univec sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30N/A
Q32025-09-30200.0%
Q42025-12-31N/A
Q12026-03-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$19.25K

+18.5%

Gross Profit

$1.66K

+304.1%

Gross Margin

8.61%

N/A

Market Cap

$8.07MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.69M

N/A

Employees

3

N/A

Net Income

-$306.32K

+1.0%

EBITDA

-$301.29K

+0.8%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$0.00

N/A

Total Debt

$1.46M

+15.8%

Accounts Receivable

$22.89K

+15.1%

Inventory

$0.00

N/A

Long Term Debt

$1.44M

+16.6%

Short Term Debt

$16.41K

-29.4%

Return on Assets

-37.77%

N/A

Return on Invested Capital

7.66%

N/A

Free Cash Flow

-$11.95K

+12.1%

Operating Cash Flow

-$11.96K

+12.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BGXXBright Green Corporation
$0.04+5328.57%
CRRTFCrescita Therapeutics, Inc.
$0.56+0.00%
OILFFNextleaf Solutions Ltd.
$0.03+2.38%
AYRWFAyr Wellness Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$19.63-0.20%
NOKNokia
$8.41-0.06%
SKHYSK Hynix
$126.79-0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$57.75-0.06%

Questions About UNVC

What is the current price of Univec?

Univec is trading at $0.00 per share.

What is the 52-week range for Univec?

Over the past 52 weeks, Univec has traded between $0.00 and $0.01.

How much debt does Univec have?

As of the most recent reporting period, Univec reported total debt of $1.46M.

How much cash does Univec have on hand?

Univec reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Univec’s dividend yield?

Univec does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services